Key facts
- Notable investors include Wuxi Capital, Skycus Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Wuxi Zhentai Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Wuxi Zhentai Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wuxi Zhentai Biotechnology
Manufacturer of a soluble micro-crystal transdermal patch intended to deliver itch-relief actives rapidly through the skin. The company offers dissolvable hyaluronic-acid micro-needles and AI-screened anti-itch molecules, enabling personal care consumers to experience fast, minimally invasive, and highly bioavailable relief.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Wuxi Zhentai Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wuxi Zhentai Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wuxi Zhentai Biotechnology in its N-PORT filings yet. We sweep new filings monthly.